ClinicalTrials.gg
CompletedNCT07840014Updated Sep 24, 2026

Effects of Acute Beetroot Juice on Aerobic Performance and Muscle Oxygenation in Amateur Female Soccer Players

An interventional study of Nitrate-rich beetroot juice and Low-nitrate blackcurrant placebo beverage in Exercise Physiology, Sports Nutrition and Cardiorespiratory Fitness, sponsored by Sakarya Applied Sciences University. Completed at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-24.

Sponsored by Sakarya Applied Sciences University · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 1 year 1 month after the study started (first participant enrolled Aug 2025, registered Sep 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
13
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

Effects of Acute Beetroot Juice on Aerobic Performance and Muscle Oxygenation in Amateur Female Soccer Players

Read the detailed description

This randomized, double-blind, placebo-controlled crossover study evaluated the acute effects of nitrate-rich beetroot juice supplementation on aerobic performance, muscle oxygenation, and selected physiological responses in amateur female soccer players.

Thirteen participants completed two experimental conditions in randomized order, separated by a 7-day washout period. In one condition, participants consumed 70 mL of nitrate-rich beetroot juice containing 6.4 mmol of nitrate, while in the other condition they consumed an equal volume of low-nitrate blackcurrant placebo containing \<0.1 mmol of nitrate. Each beverage was consumed 2.5 hours before exercise testing.

Aerobic performance was assessed using a treadmill-adapted 12-minute Cooper test. Total distance covered and estimated maximal oxygen uptake (VO₂max) were evaluated as performance outcomes. Muscle oxygen saturation was monitored using near-infrared spectroscopy. Heart rate, blood pressure, blood glucose, and rating of perceived exertion were also assessed at predefined time points. Participants and investigators conducting the experimental procedures were blinded to the supplementation condition, and the supplementation sequence was generated by an independent researcher who was not involved in the experimental procedures or statistical analyses.

02

Conditions studied

  • Exercise Physiology
  • Sports Nutrition
  • Cardiorespiratory Fitness

Keywords

  • Beetroot juice
  • Dietary nitrate
  • Aerobic performance
  • Muscle oxygenation
  • Female soccer players
03

In context

Lead sponsor

Sakarya Applied Sciences University is the lead sponsor of 5 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Female
  • Aged 18 years or older
  • Licensed soccer player for at least 3 years

Exclusion criteria

Exclusion Criteria:

  • Use of pharmacological treatment or supplements/ergogenic aids that could affect exercise performance, including stimulants such as caffeine
  • Presence of musculoskeletal, ligament, bone, neurological, or joint pathology incompatible with the exercise protocol
  • Current cardiovascular problems
  • Participation in additional sports or physical activities during the study period that could affect the study outcomes
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Participant, Investigator)
Enrollment
13 participants (actual)

Study arms

  • Experimental
    Beetroot Juice, Then Placebo

    Participants first received 70 mL of nitrate-rich beetroot juice containing 6.4 mmol nitrate. After a 7-day washout period, they received 70 mL of low-nitrate blackcurrant placebo containing \<0.1 mmol nitrate. Each beverage was consumed 2.5 hours before the 12-minute exercise test.

    Dietary Supplement: Nitrate-rich beetroot juice · Other: Low-nitrate blackcurrant placebo beverage

  • Experimental
    Placebo,Then Beetroot Juice

    Participants first received 70 mL of low-nitrate blackcurrant placebo containing \<0.1 mmol nitrate. After a 7-day washout period, they received 70 mL of nitrate-rich beetroot juice containing 6.4 mmol nitrate. Each beverage was consumed 2.5 hours before the 12-minute exercise test.

    Dietary Supplement: Nitrate-rich beetroot juice · Other: Low-nitrate blackcurrant placebo beverage

Interventions

  • Dietary supplementNitrate-rich beetroot juice

    Participants consumed a single 70 mL dose of nitrate-rich beetroot juice (Beet It Pro Elite Shot, James White Drinks Ltd., Ipswich, UK) containing 6.4 mmol (approximately 400 mg) of nitrate. The supplement was ingested 2.5 hours before the 12-minute exercise test.

  • OtherLow-nitrate blackcurrant placebo beverage

    Participants consumed a single 70 mL dose of low-calorie blackcurrant beverage (Pfanner, Austria) containing negligible nitrate (\<0.1 mmol). The placebo was ingested 2.5 hours before the 12-minute exercise test.

06

What researchers measure

Primary outcomes

  1. Distance Covered During the 12-Minute Cooper Test

    Total distance covered, expressed in meters, during a self-paced treadmill-adapted 12-minute Cooper test. Participants were instructed to cover the greatest possible distance within 12 minutes and were allowed to adjust treadmill speed throughout the test.

    Time frame: During the 12-minute exercise test performed 2.5 hours after supplementation in each crossover condition

Secondary outcomes

  1. Estimated Maximal Oxygen Uptake (VO₂max)

    Estimated maximal oxygen uptake (VO₂max), expressed as mL·kg-¹·min-¹, was calculated from the total distance covered during the treadmill-adapted 12-minute Cooper test using the classical Cooper equation.

    Time frame: At completion of the 12-minute exercise test performed 2.5 hours after supplementation in each crossover condition.

  2. Muscle Oxygen Saturation (SmO₂)

    Muscle oxygen saturation (SmO₂), expressed as a percentage, was assessed in the vastus lateralis using near-infrared spectroscopy (Moxy Monitor, Fortiori Design LLC, Spicer, MN, USA).

    Time frame: Baseline (2 minutes before warm-up), during the 12-minute exercise test, and early post-exercise (approximately 2-3 minutes after exercise) in each crossover condition.

  3. Heart Rate

    Heart rate, expressed as beats per minute, was recorded using a Polar V800 heart rate monitor. Values were summarized as the 1-minute pre-exercise mean, mean heart rate during the 12-minute exercise test, and recovery heart rate.

    Time frame: Pre-exercise, continuously during the 12-minute exercise test, approximately 2-3 minutes post-exercise, and approximately 29-30 minutes post-exercise in each crossover condition.

  4. Blood Pressure

    Blood pressure, expressed in mmHg, was measured using an automated blood pressure monitor (Omron M2, Omron Healthcare Co., Kyoto, Japan). Three consecutive readings were obtained at each time point and averaged.

    Time frame: Before supplementation, pre-exercise, 3 minutes post-exercise, and 30 minutes post-exercise in each crossover condition.

  5. Blood Glucose

    Capillary blood glucose, expressed in mg/dL, was measured from a finger-prick blood sample using a portable glucose analyzer (Plusmed Accuro, Taiwan).

    Time frame: Immediately before supplementation, pre-exercise (2 minutes before warm-up), and immediately post-exercise in each crossover condition.

  6. Rating of Perceived Exertion (RPE)

    Rating of perceived exertion was assessed using the Borg 6-20 scale, where higher scores indicate greater perceived exertion.

    Time frame: Baseline and immediately post-exercise in each crossover condition.

07

Study locations

1 site
  • Sakarya University of Applied Sciences Esentepe Campus Sports Sciences Faculty
    Sakarya, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No — The data supporting the findings of this study are available from the corresponding author upon reasonable request, subject to ethical and privacy considerations.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Aug 2025 to primary completion in Sep 2025, 1 month.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 15, 2026
First posted
Sep 24, 2026
StartActual
Aug 1, 2025
Primary completionActual
Sep 2, 2025
CompletionActual
Sep 2, 2025
Last update
Sep 24, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 24, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07840014
Lead sponsor
Sakarya Applied Sciences University
Responsible party
Melike Nur Eroğlu (lecturer doctor, Sakarya Applied Sciences University) — Principal investigator
First posted
Sep 24, 2026
Start date
Aug 1, 2025
Primary completion
Sep 2, 2025
Completion
Sep 2, 2025
Last update
Sep 24, 2026

Study contacts

MELIKE N EROGLU
principal investigator · Sakarya Applied Sciences University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion